Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

During 2016-2022, PCR testing confirmed 100 mpox cases among 302 suspected cases in the Central African Republic. The highest detection rates were from active lesions (40%) and scabs (36%); cycle thresholds were lower (≈18) than those for blood samples (≈33). Results were consistent for generic primer- and clade I primer-specific PCR tests.

Original publication

DOI

10.3201/eid2909.230514

Type

Journal article

Journal

Emerg Infect Dis

Publication Date

09/2023

Volume

29

Pages

1846 - 1849

Keywords

Central African Republic, monkeypox virus, mpox, viruses, Humans, Central African Republic, Mpox (monkeypox), Clinical Laboratory Techniques